期刊
CANCER LETTERS
卷 379, 期 2, 页码 166-172出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2016.03.033
关键词
TGF-beta signaling; Cancers; Liver cancer; GI cancers
类别
资金
- National Institutes of Health [R01CA106614, R01AA023146, P01CA130821]
- University of Texas MD Anderson Multidisciplinary Research Program
Transforming Growth Factor-beta (TGF-beta) plays crucial and complex roles in liver and gastrointestinal cancers. These include a multitude of distinct functions, such as maintaining stem cell homeostasis, promoting fibrosis, immune modulating, as a tumor suppressor and paradoxically, as a tumor progressor. However, key mechanisms for the switches responsible for these distinct actions are poorly understood, and remain a challenge. The Cancer Genome Atlas (TCGA) analyses and genetically engineered mouse models now provide an integrated approach to dissect these multifaceted and context-dependent driving roles of the TGF-beta pathway. In this review, we will discuss the molecular mechanisms of TGF-beta signaling, focusing on colorectal, gastric, pancreatic, and liver cancers. Novel drugs targeting the TGF-beta pathway have been developed over the last decade, and some have been proven effective in clinical trials. A better understanding of the TGF-beta pathway may improve our ability to target it, thus providing more tools to the armamentarium against these deadly cancers. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据